• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ShK毒素III型模拟物的设计与合成。

Design and synthesis of type-III mimetics of ShK toxin.

作者信息

Baell Jonathan B, Harvey Andrew J, Norton Raymond S

机构信息

Biomolecular Research Institute, Parkville, Victoria, Australia.

出版信息

J Comput Aided Mol Des. 2002 Apr;16(4):245-62. doi: 10.1023/a:1020214720560.

DOI:10.1023/a:1020214720560
PMID:12400855
Abstract

ShK toxin is a structurally defined, 35-residue polypeptide which blocks the voltage-gated Kv1.3 potassium channel in T-lymphocytes and has been identified as a possible immunosuppressant. Our interest lies in the rational design and synthesis of type-III mimetics of protein and polypeptide structure and function. ShK toxin is a challenging target for mimetic design as its binding epitope consists of relatively weakly binding residues, some of which are discontinuous. We discuss here our investigations into the design and synthesis of 1st generation, small molecule mimetics of ShK toxin and highlight any principles relevant to the generic design of type-III mimetics of continuous and discontinuous binding epitopes. We complement our approach with attempted pharmacophore-based database mining.

摘要

ShK毒素是一种结构明确的35个氨基酸残基的多肽,它可阻断T淋巴细胞中的电压门控Kv1.3钾通道,并已被确定为一种可能的免疫抑制剂。我们的兴趣在于蛋白质和多肽结构与功能的III型模拟物的合理设计与合成。ShK毒素是模拟设计的一个具有挑战性的目标,因为其结合表位由结合相对较弱的残基组成,其中一些是不连续的。我们在此讨论对第一代ShK毒素小分子模拟物的设计与合成的研究,并强调与连续和不连续结合表位的III型模拟物的通用设计相关的任何原则。我们通过基于药效团的数据库挖掘来补充我们的方法。

相似文献

1
Design and synthesis of type-III mimetics of ShK toxin.ShK毒素III型模拟物的设计与合成。
J Comput Aided Mol Des. 2002 Apr;16(4):245-62. doi: 10.1023/a:1020214720560.
2
A three-residue, continuous binding epitope peptidomimetic of ShK toxin as a Kv1.3 inhibitor.一种作为Kv1.3抑制剂的ShK毒素的三残基连续结合表位拟肽。
Bioorg Med Chem Lett. 2005 Jul 1;15(13):3193-6. doi: 10.1016/j.bmcl.2005.05.014.
3
Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin.由海葵毒素确定的钙激活钾通道和电压门控钾通道孔的结构保守性
J Biol Chem. 1999 Jul 30;274(31):21885-92. doi: 10.1074/jbc.274.31.21885.
4
N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.来自海葵的钾通道毒素的N端延伸类似物作为电压门控钾通道Kv1.3的强效和选择性阻滞剂。
FEBS J. 2015 Jun;282(12):2247-59. doi: 10.1111/febs.13294. Epub 2015 Apr 23.
5
Molecular mechanism of the sea anemone toxin ShK recognizing the Kv1.3 channel explored by docking and molecular dynamic simulations.通过对接和分子动力学模拟探索海葵毒素ShK识别Kv1.3通道的分子机制。
J Chem Inf Model. 2007 Sep-Oct;47(5):1967-72. doi: 10.1021/ci700178w. Epub 2007 Aug 25.
6
Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, Kv1.3.突变 ShK 毒素中的一个关键赖氨酸会改变其在电压门控钾通道 Kv1.3 的孔前庭区域的结合构型。
Biochemistry. 2002 Oct 8;41(40):11963-71. doi: 10.1021/bi026400b.
7
Role of disulfide bonds in the structure and potassium channel blocking activity of ShK toxin.二硫键在ShK毒素的结构和钾通道阻断活性中的作用。
Biochemistry. 1999 Nov 2;38(44):14549-58. doi: 10.1021/bi991282m.
8
A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3.一种 C 端酰胺化的 ShK 类似物是一种有效且选择性的电压门控钾通道 Kv1.3 阻断剂。
FEBS Lett. 2012 Nov 16;586(22):3996-4001. doi: 10.1016/j.febslet.2012.09.038. Epub 2012 Oct 9.
9
K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression.钾离子通道阻滞剂:抑制T细胞活化导致特异性免疫抑制的新型工具。
Curr Pharm Des. 2006;12(18):2199-220. doi: 10.2174/138161206777585120.
10
Designed peptide analogues of the potassium channel blocker ShK toxin.钾通道阻滞剂ShK毒素的设计肽类似物。
Biochemistry. 2001 Dec 25;40(51):15528-37. doi: 10.1021/bi011300b.

引用本文的文献

1
Recent advances in the synthesis of new benzothiazole based anti-tubercular compounds.新型苯并噻唑类抗结核化合物合成的最新进展
RSC Adv. 2023 Jul 21;13(32):21890-21925. doi: 10.1039/d3ra03862a. eCollection 2023 Jul 19.
2
Discovery of K 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.K1.3 离子通道抑制剂的发现:药物化学方法与挑战。
Med Res Rev. 2021 Jul;41(4):2423-2473. doi: 10.1002/med.21800. Epub 2021 May 1.
3
Bioactive Mimetics of Conotoxins and other Venom Peptides.芋螺毒素及其他毒液肽的生物活性模拟物

本文引用的文献

1
Design and synthesis of type-III mimetics of omega-conotoxin GVIA.ω-芋螺毒素GVIA III型模拟物的设计与合成
J Comput Aided Mol Des. 2001 Dec;15(12):1119-36. doi: 10.1023/a:1015930031890.
2
Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.选择性阻断T淋巴细胞钾通道可改善实验性自身免疫性脑脊髓炎,这是一种多发性硬化症模型。
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13942-7. doi: 10.1073/pnas.241497298.
3
Potassium channels in T lymphocytes: toxins to therapeutic immunosuppressants.
Toxins (Basel). 2015 Oct 16;7(10):4175-98. doi: 10.3390/toxins7104175.
4
Mu-conotoxins as leads in the development of new analgesics.μ-芋螺毒素在新型镇痛药研发中的作用。
Molecules. 2010 Apr 19;15(4):2825-44. doi: 10.3390/molecules15042825.
5
Structurally minimized mu-conotoxin analogues as sodium channel blockers: implications for designing conopeptide-based therapeutics.作为钠通道阻滞剂的结构最小化μ-芋螺毒素类似物:对基于芋螺肽的治疗药物设计的启示。
ChemMedChem. 2009 Mar;4(3):406-14. doi: 10.1002/cmdc.200800292.
6
K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.用于治疗神经疾病和自身免疫性疾病的钾离子通道调节剂。
Chem Rev. 2008 May;108(5):1744-73. doi: 10.1021/cr078234p.
T淋巴细胞中的钾通道:从毒素到治疗性免疫抑制剂
Toxicon. 2001 Sep;39(9):1269-76. doi: 10.1016/s0041-0101(01)00120-9.
4
Side-chain flexibility in proteins upon ligand binding.配体结合后蛋白质侧链的灵活性。
Proteins. 2000 May 15;39(3):261-8. doi: 10.1002/(sici)1097-0134(20000515)39:3<261::aid-prot90>3.0.co;2-4.
5
Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin.由海葵毒素确定的钙激活钾通道和电压门控钾通道孔的结构保守性
J Biol Chem. 1999 Jul 30;274(31):21885-92. doi: 10.1074/jbc.274.31.21885.
6
Roles of key functional groups in omega-conotoxin GVIA synthesis, structure and functional assay of selected peptide analogues.关键官能团在ω-芋螺毒素GVIA合成、选定肽类似物的结构及功能测定中的作用。
Eur J Biochem. 1999 Jun;262(2):447-55. doi: 10.1046/j.1432-1327.1999.00383.x.
7
Protein-protein recognition: an experimental and computational study of the R89K mutation in Raf and its effect on Ras binding.蛋白质-蛋白质识别:Raf中R89K突变及其对Ras结合影响的实验与计算研究
Protein Sci. 1999 Jan;8(1):50-64. doi: 10.1110/ps.8.1.50.
8
Analysis of protein-protein interactions by mutagenesis: direct versus indirect effects.通过诱变分析蛋白质-蛋白质相互作用:直接效应与间接效应
Protein Eng. 1999 Jan;12(1):41-5. doi: 10.1093/protein/12.1.41.
9
Structural response to mutation at a protein-protein interface.蛋白质-蛋白质界面处突变的结构响应。
J Mol Biol. 1999 Mar 12;286(5):1487-506. doi: 10.1006/jmbi.1998.2559.
10
ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide.ShK-Dap22,一种强效的Kv1.3特异性免疫抑制多肽。
J Biol Chem. 1998 Dec 4;273(49):32697-707. doi: 10.1074/jbc.273.49.32697.